The move comes in response to an outbreak of mysterious lung illnesses tied to vaping, in today's bite-sized hospital and health industry news from Connecticut, New York, and Virginia.
Daily Briefing's Jackie Kimmell breaks down five stories you should know about the moves Big Tech disruptors have made in the past month—and how they could impact the health care industry.
The Trump administration on Wednesday announced that FDA intends to finalize a compliance policy that will clear the market of unauthorized, non-tobacco-flavored e-cigarettes, including mint and menthol flavors, in response to growing numbers of children using e-cigarettes.
FDA recently released draft guidance that calls on researchers to include more male patients in clinical trials for breast cancer treatments in response to concerns that men are missing out on "lifesaving therapies," Roni Rabin reports for the New York Times.
When it's time to negotiate, people "tend to believe niceness will buy them better deals," but Martha Jeong, an assistant professor of management at the Hong Kong University of Science and Technology, and her colleagues at Harvard University have found that "when put to the test, this prediction turns out to be wrong," they write for Harvard Business Review.
Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have reached a tentative settlement with nearly two dozen states and thousands of U.S. cities, counties, and territories suing the company for allegedly contributing to the U.S. opioid epidemic.
